Answers are grounded in this paper and cite their sources.
β-thalassemia is a group of inherited blood disorders that affect the production of β-globin chains, leading to the reduction or absence of these chains. One of the complications observed in patients with β-thalassemia major (β-TM) is thrombosis, especially in those who receive frequent blood transfusions. This may be due to a decrease in the levels of the natural anticoagulants: protein C (PC), total protein S (PS), and antithrombin (AT).
No takes yet. Share an insight, caveat, or question.
Ahmadi et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: